The ubiquitin (Ub) kinase PINK1 and the E3 Ub ligase Parkin, two gene products associated with young-onset Parkinson's disease (PD), participate in mitochondrial quality control. The phosphorylation of mitochondrial polyUb by PINK1, which is activated in a mitochondrial membrane potential (DWm)-dependent manner, facilitates the mitochondrial translocation and concomitant enzymatic activation of Parkin, leading to the clearance of phospho-polyUb-tagged mitochondria via mitophagy. Thus, Ub phosphorylation is a key event in PINK1-Parkin-mediated mitophagy. Here, we examined the role of phospho-Ub signaling in the pathogenesis of PD using fly PD models, human brain tissue and dopaminergic neurons derived from induced pluripotent stem cells (iPSCs) containing Parkin or PINK1 mutations, as well as normal controls. We report that phospho-Ub signaling is highly conserved between humans and Drosophila, and that phospho-Ub signaling and the relocation of axonal mitochondria upon DWm reduction are indeed compromised in human dopaminergic neurons containing Parkin or PINK1 mutations. Moreover, phospho-Ub signaling is prominent in tyrosine hydroxylase-positive neurons compared with tyrosine hydroxylase-negative neurons, suggesting that PINK1-Parkin signaling is more required for dopaminergic neurons. These results shed light on the particular vulnerability of dopaminergic neurons to mitochondrial stress.
Introduction
Parkin is an RBR (RING-in-between-RING) ubiquitin ligase (E3) with an N-terminal ubiquitin-like (Ubl) domain (1) (2) (3) . The PINK1 gene encodes a serine/threonine kinase with a predicted mitochondrial targeting sequence and a putative N-terminal transmembrane domain (4) . Parkin and PINK1 gene mutations promote the selective degeneration of midbrain dopaminergic neurons without gliosis, which is characterized as autosomal recessive juvenile Parkinson's disease (PD) and associated with the PARK2 and PARK6 loci, respectively (5, 6) . These pathological features strongly suggest that PINK1-Parkin signaling is indispensable for the survival of the dopaminergic neurons.
Drosophila genetic studies have revealed that PINK1 is an upstream regulator of Parkin, regulating mitochondrial quality control (7) (8) (9) . Cell biological studies have provided evidence that PINK1 and Parkin regulate mitochondrial homeostasis by removing damaged mitochondria via mitophagy (10) (11) (12) (13) (14) . PINK1 on healthy mitochondria is transported to the mitochondrial inner membrane in a mitochondrial membrane potential (DWm)-dependent manner and undergoes constitutive proteolysis through a series of mitochondrial proteases and the proteasome (15) . When mitochondria are accidentally damaged, DWm is reduced, leading to the accumulation and activation of PINK1 on the mitochondrial outer membrane (11) . PINK1 activation transforms the latent, cytosolic form of Parkin into an active E3 ligase on damaged mitochondria by phosphorylating Ser65 of both ubiquitin (Ub) and the Parkin Ubl domain (3, (16) (17) (18) (19) (20) . Activated Parkin forms polyUb chains on damaged mitochondria, which are subsequently phosphorylated by PINK1 to produce phospho-polyUb chains (21) (22) (23) . Mitochondrial phospho-polyUb chains further facilitate the mitochondrial retention and activation of the remaining latent form of Parkin, whereby new phospho-polyUb chains are produced by Parkin in conjunction with PINK1 (21) (22) (23) . Thus, there is an amplification cascade of Parkin activation and mitochondrial translocation through phospho-polyUb production. Mitochondria decorated with phospho-polyUb chains are subsequently recognized by autophagy receptors such as p62/SQSTM1, Optineurin and NDP52, which are activated via phosphorylation by TBK1, a downstream kinase of PINK1 (24) (25) (26) . Activated autophagy receptors promote bridging between phospho-polyUb chains and LC3/ATG8, leading to LC3-mediated autophagy (27) . Thus, PINK1 and Parkin effectively remove only damaged mitochondria via autophagy.
Ub phosphorylation is emerging as novel key regulator of the PINK1-Parkin pathway in cultured cells. The absence of phospho-Ub signals has been reported in fibroblasts, induced pluripotent stem cell (iPSC)-derived neurons and human brain tissues from PINK1 patients, whereas phospho-Ub signals were shown to accumulate in human brain tissues from older subjects and in PD and amyotrophic lateral sclerosis patients (28) , indicating that Ub phosphorylation is relevant to PD and neurodegenerative diseases associated with mitochondrial dysfunctions. The mitochondrial expression of phospho-mimetic polyUb chains also suppresses mitochondrial degeneration caused by loss of PINK1 in Drosophila (22), supporting a role for Ub phosphorylation in the PINK1-Parkin pathway in vivo. However, how phospho-polyUb signaling is altered by disease-associated Parkin mutations remains unknown, particularly in midbrain dopaminergic neurons, considering the characteristic etiology of PARK2 and PARK6, namely, the selective degeneration of the dopamine system in the substantia nigra (29, 30) . To address this issue, we characterized phospho-Ub signaling in Drosophila, human postmortem brain tissues and dopaminergic neurons derived from normal subjects and from subjects harboring PARK2 or PARK6 mutations. Here, we report that phospho-Ub generated by PINK1 is primarily involved in human dopaminergic neurons, that phospho-Ub production is compromised in dopaminergic neurons from PARK2 and PARK6 patients, and that the principal mechanism of phospho-Ub signaling is also conserved in Drosophila.
Results

Phospho-polyUb signals are involved in mitochondrial maintenance in Drosophila
The mitochondria of the indirect flight muscles degenerate in PINK1-deficient or Parkin-deficient Drosophila (7-9,31). Expressing phospho-mimetic polyUb chains on mitochondria rescues the mitochondrial degeneration caused by the loss of PINK1, suggesting that endogenous Parkin is activated by phospho-mimetic polyUb in PINK1-deficient flies (22) . To further confirm these findings, we examined the involvement of phospho-ubiquitin signals in vivo. Whereas both PINK1 À/À and Parkin À/À flies exhibited similar mitochondrial phenotypes, which were rescued by Parkin overexpression, the upstream kinase PINK1 was likely to accumulate and become activated in the mitochondria of Parkin À/À flies (Fig. 1A) . As shown in Figure   1B , phospho-polyUb signals prominently accumulated in the indirect flight muscles of 14-day-old Parkin À/À flies, which showed reduced mitochondrial complex I subunit NDUFS3 and upregulated mitochondrial Hsp60, whereas phospho-polyUb signals completely disappeared when Parkin was re-expressed in agematched Parkin À/À flies. No phospho-polyUb was detected in PINK1 À/À muscle tissues with either degenerated or healthy mitochondria following Parkin overexpression, strongly suggesting that polyUb phosphorylation is exclusively mediated by PINK1 (Fig. 1B) . By contrast, total polyUb levels were similar among all four genotypes, indicating that a small portion of the polyUb chains is phosphorylated (Fig. 1B) .
Age-dependent reduction in the phospho-polyUb signal in Parkin-deficient Drosophila
Whereas phospho-polyUb signals significantly accumulated in the indirect flight muscles of 14-day-old Parkin À/À flies, the signals almost disappeared in 30-day-old flies, in which NDUFS3 protein levels were reduced to those of age-matched Parkin À/À flies. These results suggest that phospho-Ub chains decreased in an age-dependent manner and that the constitutive overexpression of Parkin does not fully rescue Parkin mitochondrial phenotypes throughout the fly lifespan ( Fig. 1C and D ). By contrast, Hsp60 levels were reduced in both 14-and 30-day-old Parkin À/À flies re-expressing Parkin, suggesting that mitochondrial stress is partially relieved by Parkin ( Fig. 1C and D) .
Phospho-polyUb signals in Drosophila brain tissues
We next examined the involvement of phospho-polyUb signals in dopaminergic neurons of adult fly brain. As shown in Figure  2A ; LacZ flies (arrows in Fig. 2B ) and some of neuropils were anti-TH-positive (inserts in Fig. 2B ). These results suggest that phospho-Ub is dominantly accumulated in the nerve terminals of neurons including dopaminergic neurons in Parkin ; Parkin flies. We also observed cells with PINK1-independent anti-phospho-Ub signals, which were located adjacent to the PPM2 cluster (arrowheads in Fig. 2 ). The signals are likely to be produced by an uncharacterized kinase other than PINK1 or to be unspecific signals.
Phospho-polyUb signals in human brain tissues
Given that phospho-polyUb signals were detected in the muscle and brain tissues of Parkin-deficient flies, we next examined the phospho-polyUb signals via histochemical analysis using autopsied brain tissues from patients with different diseases, including sporadic PD, genetic PD caused by PINK1 (PARK6) or Parkin (PARK2) mutations and multiple system atrophy (MSA), in addition to Parkin-deficient mice. Specific phospho-Ub signals with punctate distributions were observed in the midbrain dopaminergic neurons of one autopsied brain out of four sporadic PD cases (Fig. 3A) , whereas no significant phospho-polyUb signals were observed in dopaminergic neurons of the substantia nigra of healthy controls and PARK2-, PARK6- (Fig. 3A) and Parkin-deficient mice (Supplementary Material, Fig. S1 ). The phospho-Ub signals were distributed throughout the cytosol of dopaminergic neurons in a punctate pattern and were partly co-localized with mitochondria (Fig. 3B) . Lewy bodies were not stained with the anti-phospho-Ub (data not shown). In the MSA case, in which a-Synuclein-and ubiquitin-positive glial cytoplasmic inclusions were observed upon pathological examination, no overlap was observed between poly-ubiquitin signals and phospho-Ub signals (Fig. 3A) .
Phospho-polyUb signals in human dopaminergic neurons
Given that only one autopsied PD subject was phospho-Ubpositive and that phospho-polyUb disappeared in aged Fig. 4 ), indicating that the DWm was preserved to such an extent that PINK1 was inactive. Consequently, we induced mitochondrial stress in TH-positive neurons using 1 mM valinomycin, which reduces DWm and activates PINK1. After a 12-h valinomycin treatment, PINK1 accumulated to a similar extent in both control and PAKR2 cells (lanes 10, 12 and 14, Fig. 4 ). The prominent accumulation of phospho-polyUb signals was observed in control cells, whereas the production of phospho-polyUb signals was impaired but could still be detected in PARK2 cells (lanes 4 and 6 vs. lane 2, Fig. 4 ), suggesting that activated PINK1 phosphorylated constitutively generated mitochondrial polyUb chains or cytosolic polyUb chains, even in the absence of Parkin. As reported previously in non-neuronal cells, the mitochondrial outer membrane proteins Mitofusin 1 (Mfn1) and Miro1, which are well-known Parkin substrates (33) (34) (35) , were degraded at 12 h post valinomycin treatment in a Parkin-dependent manner (lane 10 vs. lane 9, Fig. 4 ), whereas the degradation of these proteins was impaired in PARK2 and PARK6 cells (lanes 12, 14 and 16 vs. lanes 11, 13 and 15, Fig. 4 ). The protein levels of the mitochondrial outer membrane translocase subunit Tom20, which is degraded by PINK1-Parkin-mediated mitophagy, were reduced in PARK2 PA cells and in normal controls. Unlike the parkin mutation in PB cells, in which the parkin gene structure encoding the RING1 and IBR domains is disrupted, a homozygous exon 2-4 deletion of the parkin genes in PA cells preserves the intact gene structure to produce a truncated Parkin protein containing RING1, IBR and RING2 domains (32) . Thus, we cannot exclude the effects of residual Parkin activity on mitochondria, although we did not detect truncated Parkin product(s) via western blotting. Consistent with a previous report, the phosphorylation of TBK1 at S172, which activates the downstream autophagy pathway, was dependent on PINK1 (lanes 15 and 16 vs. lanes 9-14, Fig. 4 ) (25) . Intriguingly, however, TBK1 was constitutively phosphorylated at S172, even in non-treated cells harboring intact PINK1 genes and was not dependent on PINK1 accumulation (lanes 9, 11 and 13 vs. lanes 10, 12 and 14, Fig. 4 ).
Phospho-polyUb signals localize to the mitochondria of dopaminergic neurons
We next examined the subcellular localization of phospho-Ub signals in neurons. Consistent with the western blot results, we detected no phospho-Ub signals in condensed TH-positive neuronal cultures derived from control ( Fig. 5A ) and PARK2 iPSCs (data not shown) under steady-state conditions. Upon valinomycin treatment for 24 h, phospho-polyUb signals were primarily detected in the perinuclear region of TH-positive control neurons, colocalizing with aggregated mitochondria (Fig. 5B-D  and Supplementary Material, Fig. S3 ). In addition, mitochondrial phospho-Ub signals in neural processes were predominantly detected at an early stage of DWm reduction (i.e., 12-h post valinomycin treatment) ( Fig. 5F and G) . Consistent with our western blot results, phospho-polyUb signals were largely absent in PARK2 cells (Fig. 5E) .
We next examined whether mitophagy occurs in dopaminergic neurons with depolarized mitochondria. Whereas the mitochondrial matrix protein Hsp60 was detected in both control and PARK2 dopaminergic neurons 12-h post mitochondrial depolarization with valinomycin (Fig. 6A) , Hsp60 immunosignals disappeared in control neurons by 48 h, suggesting that mitochondria are removed via mitophagy (Fig. 6B) . By contrast, Hsp60 signals persisted in the cell bodies of PARK2 neurons during this period (Fig. 6B) .
Optineurin but not p62/SQSTM1 or NDP52 is involved in mitophagy of dopaminergic neurons Optineurin and NDP52 are suggested to play a major role as autophagy receptors in PINK1/Parkin-mediated mitophagy (24, 25) . p62/SQSTM1 has been also reported to be involved in PINK1/Parkin-mediated mitophagy (14, 36, 37) . We thus determined whether Optineurin, NDP52 and p62 are expressed in human dopaminergic neurons. As reported, Optineurin, NDP52 and p62 were expressed in HeLa cells, in which PINK1-Parkin signaling has been well characterized (Fig. 7A) (24, 25) . In sharp contrast to HeLa cells, NDP52 and p62 were not detected in condensed TH-positive neuronal cultures (Fig. 7A) . The result was consistent with previous findings that NDP52 and p62 are less or not expressed in neural tissues (24, 38, 39) . We confirmed that Optineurin is recruited to mitochondria in the cell bodies and the neurites of dopaminergic neurons along with LAMP1, a late endosome/lysosome marker, during mitophagy ( Fig. 7B and  C) . These results suggest that NDP52 and p62 may not be important for PINK1/Parkin-mediated mitophagy in dopaminergic neurons although Optineurin functions as an autophagy receptor.
Mitochondrial quality control in neural processes is disturbed in PARK2 and PARK6 dopaminergic neurons
Whether efficient mitophagy occurs in the axonal processes of neurons remains controversial (40, 41) . The retrograde flux of mitochondria with low DWm becomes predominant (40, 42) , likely involving PINK1-Parkin-mediated Miro degradation (34, 35) . In one study, this mitochondrial flux change stimulated the accumulation of damaged mitochondria in cell bodies, where mitophagy occurs (40) . Another study showed that endogenous Parkin contributes to the removal of axonal mitochondria along with LC3 and lysosomes (41) . Phospho-Ub signals on neurite mitochondria were also detected after valinomycin treatment for 12-h ( Fig. 5F and G) , and the disappearance of mitochondria from neurites was also observed (Control in Supplementary Material, Fig. S4 ). At this time-point, Mfn1 and Miro1 protein levels, but not Hsp60 levels, were reduced (Supplementary Material, Fig. S5 ), suggesting that most mitochondria were relocated but not removed through mitophagy.
In this context, the number and density of axonal mitochondria in PARK2 and PARK6 dopaminergic neurons were unchanged or rather increased after 24-h valinomycin treatment (Fig. 8A-C) . Similar results were observed with 12-h valinomycin treatment (Supplementary Material, Fig. S4) . 
Phospho-polyUb signals are accentuated in dopaminergic neurons
We found that the intensity of phospho-Ub signals is different in cell type. Intriguingly, phospho-Ub signals were prominent in TH-positive dopaminergic neurons compared with TH-negative neurons (Fig. 8D ) and other uncharacterized cells (arrowheads in Fig. 5D ). Phospho-Ub signals were detected in 86% of THpositive neurons, whereas only 29% of TH-negative neurons were phospho-Ub-positive (Fig. 8D) , indicating that dopaminergic neurons have higher PINK1-Parkin signaling activity.
Discussion
Disturbances to PINK1-Parkin signaling-dependent mitochondrial quality control are believed to cause early-onset PD. The phosphorylation of Ub and Parkin by PINK1 is a key event that drives Parkin to remove damaged mitochondria through mitophagy, which is thought to regulate mitochondrial homeostasis during cellular activity. In the present study, we investigated the involvement of phospho-Ub signaling in Drosophila, mice and human subjects to confirm its disease relevance. In contrast to the results in fly models, we observed no significant anti-phospho-Ub immunosignals in the substantia nigra dopaminergic neurons of PARK2 brain tissues and aged Parkin knockout mice. We also detected no phospho-Ub signals in the muscles of aged Parkin À/À flies. Thus, the absence of phospho-Ub signals in aged mouse brains and PARK2 brains likely reflects differences in a specific timing of phospho-Ub expression during disease progression. Nevertheless, we detected phospho-Ub signals in substantia nigra dopaminergic neurons from a sporadic PD case, which indicates that PINK1-Parkin signaling is associated with at least a portion of sporadic PD. Expanding the analysis to include more disease cases associated with mitochondrial dysfunctions, including PD cases, will be necessary to address this issue.
Although human brain autopsies reveal what remains after neurodegeneration in PD, dopaminergic neurons from patient iPSCs would be more suitable to understand disease progression without postmortem changes, including dephosphorylation and disintegration. Using patient-derived dopaminergic neurons, we confirmed that mitochondrial relocation in axons upon DWm reduction is indeed impaired in PARK2 and PARK6 patients, consistent with previous finding in which the motility of damaged axonal mitochondria was suppressed by the degradation of Miro via PINK1-Parkin signaling (18, 35) . Thus, the quality control of axonal mitochondria must be a key event in the survival of dopaminergic neurons. Supporting this idea, phospho-Ub signals were accumulated in the neuropils rather than the cell bodies of neurons in Drosophila.
Another important finding is that phospho-Ub signals are prominent in dopaminergic neurons compared with nondopaminergic neurons, which may be explained as follows: first, Parkin or PINK1 expression is higher in dopaminergic neurons, although we were unable to detect endogenous Parkin via immunocytostaining due to the lack of suitable anti-Parkin antibodies. However, the expression of Parkin and PINK1 transcripts in the substantia nigra is not higher than that in other brain regions (5,43). Second, mitochondrial stress is higher in dopaminergic neurons, as oxidative stress based on a higher metabolic rate and dopamine toxicity are well documented (44) . In addition, the pacemaking property of dopaminergic neurons, which involves large Ca influxes from L-type Ca 2þ channels, could stimulate the production of mitochondrial reactive oxygen species (ROS) (45) . Higher mitochondrial stress caused by these factors is likely to potentiate the phospho-Ub signals accompanied by PINK1-Parkin activation, as higher ROS production accelerates Parkin mitochondrial translocation in neurons (46) .
In conclusion, our study has demonstrated that PINK1-Parkin signaling faithfully functions in human dopaminergic neurons and in Drosophila and that mitochondrial behaviors in PARK2 and PARK6 dopaminergic neurons are indeed altered, including weak or no phospho-Ub accumulation at damaged mitochondria and the impaired relocation of axonal mitochondria upon DWm reduction, suggesting that the disturbance of mitochondrial quality control in axons is one of causes of PARK2-and PARK6-linked PD. Moreover, the most important finding here is that phospho-Ub signaling mediated by PINK1-Parkin is evidently stronger than that in other neurons, indicating that PINK1-Parkin signaling is indispensable for dopaminergic neuron survival. Resolving the factors that contribute to this phenomenon would provide insights into the selective degeneration of dopaminergic neurons in PARK2-and PARK6-linked PD and in PD, via mitochondrial dysfunction.
Materials and Methods
Antibodies
The following antibodies were used in western blotting: antiphospho-Ub (1:1000 dilution; Millipore, ABS1513), anti-PINK1 
Drosophila genetics
Fly culture and crosses were performed using standard fly food containing yeast, cornmeal and molasses, and flies were raised at 25 C. All fly stocks and GAL4 lines used in this study were obtained from the Bloomington Drosophila Stock Center and have been described previously: The following genotypes were used (shown in Fig. 1 ): 
Immunofluorescence staining of brain tissues
Multiple immunofluorescence staining was performed using 10-lm-thick, formalin-fixed, paraffin-embedded sections from the substantia nigra of clinically diagnosed and pathologically or genetically confirmed PD and control cases collected by the Department of Neurology, Jutendo University Hospital and Brain Research Institute, Niigata University and approved by the Ethical Committees of Juntendo University and Niigata University. Deparaffinized sections microwaved in citrate buffer, pH 6.0, for 7 min for antigen retrieval were neutralized with Tris-buffered saline (TBS, pH 7.4). The sections were blocked with TBS containing 0.1% (w/v) gelatin for 1 h and incubated overnight with primary antibodies at 4 C. The primary antibodies were visualized using secondary antibodies (1: 1,000, Alexa Fluor405, 488, 549, and 647, Thermo Fisher Scientific) for 1 h at RT. To reduce lipofuscin autofluorescence, the sections were further treated with the TrueBlack Lipofuscin Autofluorescence Quencher (Cosmo Bio) diluted in 70% ethanol for 30 s and washed briefly with TBS prior to mounting with Fluoro-KEEPER Antifade Reagent (Nacalai Tesque) and were assessed using a TCS-SP5 laser-scanning microscope system (Leica Microsystems). The clinical information on the subjects are shown in Supplementary Material, Table S1 . For the analysis of TH-positive neurons in Drosophila brain tissues, whole-mount immunostaining was performed as described previously (49) .
Human iPSCs
For control lines, we used two human iPSC lines: 201B7 was kindly provided by Dr. Shinya Yamanaka at Kyoto University (50), and EKA4 was described previously (51) . For the PD lines, the PARK2 iPSC lines (PA and PB) were described previously (32) . PARK6 iPSC line (PKB) was newly generated from the dermal fibroblasts of a 61-year-old Japanese female patient using retrovirally expressed Oct4, Sox2, Klf4, and c-Myc to reprogram the cells, as previously described (32, 50) . Human dermal fibroblast maintenance, retroviral production, infection, stem cell culture and characterization were performed as described previously (32, 51) . Table S1 .
In vitro differentiation of human iPSCs
Human iPSCs were differentiated into dopaminergic neurons using a previously described protocol, with slight modifications (51) (52) (53) . Neurospheres were repeatedly passaged by dissociation into single cells and subsequently cultured as previously described (51) (52) (53) . Neurospheres at passages 2-4 were typically used for analysis. For dopaminergic neuron differentiation, dissociated neurospheres were adhered to poly-L-ornithine (Sigma-Aldrich)-and laminin (GIBCO)-coated cultured plates or coverslips (Matsunami) and cultured in media hormone mix containing B27 (GIBCO), 10 ng/ml brain-derived neurotrophic factor (BDNF; R&D systems), 10 ng/ml glial cell-derived neurotrophic factor (GDNF; R&D systems), 200 mM ascorbic acid (Sigma-Aldrich), 1 mM dibutyryl-cAMP (Sigma-Aldrich), 1 ng/ml TGF-b (R&D systems) and 10 mM DAPT (Sigma-Aldrich) for 14 days.
Imaging of neuronal cultures, Drosophila mitochondria and western blotting
Cells plated on poly-L-ornithine-and laminin-coated coverslips were treated with or without 1 mM valinomycin and then stained with the indicated antibodies as described (16) . The cells were imaged using a laser-scanning microscope system (TCS-SP5, Leica). For mitochondrial quantification in dopaminergic neurons, a line was drawn along the axon as an ROI, and the number and length of mitochondrial signals were analysed using ImageJ software. Axons were selected based on morphological characteristics as described (40) . The average number of mitochondria and total mitochondria length in the unit length of the axon (50 mm) were calculated. The mitochondrial morphology of the Drosophila indirect flight muscles was analysed by transmission electron microscopy as described previously (49) . Western blotting using cultured cells and Drosophila tissue samples was performed as described, using ECL prime solution (GE Healthcare) (16, 18) . Blot images were obtained using an Image Quant LAS 4000 mini (GE Healthcare).
Parkin knockout mice
Parkin mutant mice harboring the parkin mutant gene, in which exon 2 was replaced with s-GFP, have been described elsewhere (54) . Animal experiments were approved by the Experimental Animal Committees of Juntendo University.
Statistical analysis
Two-tailed Student's t-test was used to determine significant differences between two groups. For axonal mitochondrial comparisons among multiple groups, Steel's test was used after Bartlett's test for equality of variance.
Supplementary Material
Supplementary Material is available at HMG online.
